Almangour TA, Ghonem L, Alassiri D, Aljurbua A, Al Musawa M, Alharbi A, Almohaizeie A, Almuhisen S, Alghaith J, Damfu N, Aljefri D, Alfahad W, Khormi Y, Alanazi MQ, Alsowaida YS. Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the treatment of infections caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study. Antimicrob Agents Chemother. 2023;67(8):e0040523.

Article  PubMed  Google Scholar 

Boutin S, Nurjadi D. The lung microbiome in cystic fibrosis: a gap of knowledge still to be filled. J Cyst Fibros. 2023;22(4):595–6.

Article  PubMed  Google Scholar 

Cendra MDM, Torrents E. Pseudomonas aeruginosa biofilms and their partners in crime. Biotechnol Adv. 2021 Jul-Aug;49:107734.

Chan EG, Hyzny EJ, Ryan JP, Morrell MR, Pilewski J, Sanchez PG. Outcomes following lung retransplantation in patients with cystic fibrosis. J Cyst Fibros. 2022;21(3):482–8.

Article  PubMed  Google Scholar 

Congedi S, Navalesi P, Boscolo A. Multidrug-resistant organisms in lung transplant: a narrative review. Curr Opin Organ Transpl. 2023;28(3).

De Muynck B, Van Herck A, Sacreas A, Heigl T, Kaes J, Vanstapel A, Verleden SE, Neyrinck AP, Ceulemans LJ, Van Raemdonck DE, Lagrou K, Vanaudenaerde BM, Verleden GM, Vos R. Leuven Lung Transplant Group. Successful Pseudomonas aeruginosa eradication improves outcomes after lung transplantation: a retrospective cohort analysis. Eur Respir J. 2020;56(4):2001720.

Article  PubMed  Google Scholar 

Dobbin C, Maley M, Harkness J, et al. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. J Hosp Infect. 2004;56(4):277–82.

Article  CAS  PubMed  Google Scholar 

Dupont L. Lung transplantation in cystic fibrosis patients with difficult to treat lung infections. Curr Opin Pulm Med. 2017;23(6):574–9.

Article  PubMed  Google Scholar 

Marita Gilljam U, Nyström Göran, Dellgren I, Skog L, Hansson. Survival after lung transplantation for cystic fibrosis in Sweden†. Eur J Cardiothorac Surg. March 2017;51(3):571–6.

Gutiérrez Santana JC, Coria Jiménez VR. Burkholderia cepacia complex in cystic fibrosis: critical gaps in diagnosis and therapy. Ann Med. 2024;56(1).

Harvey BJ, McElvaney NG. Sex differences in airway disease: estrogen and airway surface liquid dynamics. Biol Sex Differ. 2024;15(1):56.

Article  PubMed  PubMed Central  Google Scholar 

Healey N. The gender gap in cystic fibrosis–. Nature. 2020;583(7818):10–1.

Article  Google Scholar 

Huang W, Smith AT, Korotun M, Iacono A, Wang J. Lung Transplantation in a new era in the field of cystic fibrosis. Life (Basel). 2023;13(7).

Jurado-Martín I, Sainz-Mejías M, McClean S. Pseudomonas aeruginosa: An Audacious Pathogen with an adaptable Arsenal of virulence factors. Int J Mol Sci. 2021;22(6).

Langer F, Aliyev P, Schäfers HJ, et al. Improving outcomes in Bridge-to-Transplant: extended extracorporeal membrane oxygenation support to Obtain Optimal Donor lungs for marginal recipients. ASAIO J. 2019;65(5):516.

Article  CAS  PubMed  Google Scholar 

Kim HB, Na S, Paik HC, Joo H, Kim J. Risk factors for intensive care unit readmission after lung transplantation: a retrospective cohort study. Acute Crit Care. 2021;36(2):99–108.

Lay C, Law N, Holm AM, Benden C, Aslam S. Outcomes in cystic fibrosis lung transplant recipients infected with organisms labeled as pan-resistant: An ISHLT Registry–based analysis. J Heart Lung Transplant. 2019;38(5):545-552.

Liao C, Huang X, Wang Q, Yao D, Lu W. Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance. Front Cell Infect Microbiol. 2022;12:926758.

Lobo LJ, Noone PG. Respiratory infections in patients with cystic fibrosis undergoing lung transplantation. Lancet Respir Med. 2014;2(1):73–82.

Luong ML, Chaparro C, Stephenson A, Rotstein C, Singer LG, Waters V, Azad S, Keshavjee S, Tullis E, Husain S. Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis. Transplantation. 2014;97(3):351-7.

Lynch JP 3rd, Sayah DM, Belperio JA, Weigt SS. Lung transplantation for cystic fibrosis: results, indications, complications, and controversies. Semin Respir Crit Care Med. 2015;36(2):299-320.

Middleton PG, Mall MA, Dřevínek P, Lands LC, McKone EF, Polineni D, Ramsey BW,Taylor-Cousar JL, Tullis E, Vermeulen F, Marigowda G, McKee CM, Moskowitz SM, Nair N, Savage J, Simard C, Tian S, Waltz D, Xuan F, Rowe SM, Jain R; VX17-445-102 Study Group. Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele. N Engl J Med. 2019;381(19):1809–1819.

Parkins MD, Somayaji R, Waters VJ. Epidemiology, Biology, and Impact of ClonalPseudomonas aeruginosa Infections in Cystic Fibrosis. Clin Microbiol Rev. 2018;31(4):e00019-18. Published 2018 Aug 29. https://doi.org/10.1128/CMR.00019-18

Ramos KJ, Kapnadak SG, Bradford MC, Somayaji R, Morrell ED, Pilewski JM, Lease ED, Mulligan MS, Aitken ML, Gries CJ, Goss CH. Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation: A United Network for Organ Sharing Registry Study. Chest. 2020;157(4):898–906.

Reece E, Segurado R, Jackson A, McClean S, Renwick J, Greally P. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis. BMC Pulm Med. 2017;17(1):70.

Schwarz C, Eschenhagen PN, Mainz JG, Schmidergall T, Schuette H, Romanowska E.Pulmonary Aspergillosis in People with Cystic Fibrosis. Semin Respir Crit Care Med. 2024;45(1):128–140.

Saint-Criq V, Kim SH, Katzenellenbogen JA, Harvey BJ. Non-genomic estrogen regulation of ion transport and airway surface liquid dynamics in cystic fibrosis bronchial epithelium. PLoS One. 2013;8(11):e78593.

Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms:a nation-wide five-year time lapse analysis. Lancet Reg Health Eur. 2023;34:100736.

Schwarz C, Bend J, Hebestreit H, Hogardt M, Hügel C, Illing S, Mainz JG, Rietschel E, Schmidt S, Schulte-Hubbert B, Sitter H, Wielpütz MO, Hammermann J, Baumann I, Brunsmann F, Dieninghoff D, Eber E, Ellemunter H, Eschenhagen P, Evers C, Gruber S, Koitschev A, Ley-Zaporozhan J, Düesberg U, Mentzel HJ, Nüßlein T, Ringshausen FC, Sedlacek L,Smaczny C, Sommerburg O, Sutharsan S, Vonberg RP, Weber AK, Zerlik J. S3-Leitlinie:Lungenerkrankung bei Mukoviszidose – Pseudomonas aeruginosa [CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa]. Pneumologie. 2024;78(6):367–399.

Shou BL, Kalra A, Zhou AL, Barbur I, McGoldrick MT, Larson E, Keller SP, Kim BS,Whitman GJR, Cho SM, Bush EL. Impact of Extracorporeal Membrane Oxygenation Bridging Duration on Lung Transplant Outcomes. Ann Thorac Surg. 2024;118(2):496–503.

Shteinberg M, Haq IJ, Polineni D, Davies JC. Cystic fibrosis. Lancet. 2021;397(10290):2195–2211.

Stefani S, Campana S, Cariani L, et al. Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis. Int J Med Microbiol. 2017;307(6):353-362.

Taylor-Robinson D, Schlüter DK, Diggle PJ, Barrett JK. Explaining the Sex Effect on Survival in Cystic Fibrosis: a Joint Modeling Study of UK Registry Data. Epidemiology. 2020;31(6):872–879.

Trouvé P, Saint Pierre A, Férec C. Cystic Fibrosis: A Journey through Time and Hope. Int J Mol Sci. 2024;25(17):9599

Tyrrell J, Harvey BJ. Sexual dimorphism in the microbiology of the CF ‘Gender Gap’: Estrogen modulation of Pseudomonas aeruginosa virulence. Steroids. 2020;156:108575.

Yeung JC, Machuca TN, Chaparro C, Cypel M, Stephenson AL, Solomon M, Saito T,Binnie M, Chow CW, Grasemann H, Pierre AF, Yasufuku K, de Perrot M, Donahoe LL, Tikkanen J, Martinu T, Waddell TK, Tullis E, Singer LG, Keshavjee S. Lung transplantation for cystic fibrosis. J Heart Lung Transplant. 2020;39(6):553–560.